1. Preliminary coronavirus vaccine trials show promise  CBS This Morning
  2. Oxford expands virus vaccine trial to older adults and children  Daily Monitor
  3. Oxford researchers announce phase II and phase III human trials of COVID-19 vaccine - Republic World  Republic World
  4. A Vaccine With a Poison Pill  Bloomberg
  5. Moderna Shares Up Almost 250% This Year as Vaccine Trials Continue  Nasdaq
  6. View Full coverage on Google News
Up to 10,260 adults and children will be enrolled as it expands the age range of people given the specimen vaccine and involves a number of partner institutions across BritainUp to 10,260 adults and children will be enrolled as it expands the age range of people given the specimen vaccine and involves a number of partner institutions across Britain

Oxford expands virus vaccine trial to older adults and children - Daily Monitor

Oxford University scientists, working to develop a vaccine for COVID-19, have started recruiting candidates for Phases II and III of human clinical trials.Oxford University scientists, working to develop a vaccine for COVID-19, have started recruiting candidates for Phases II and III of human clinical trials.

Oxford researchers announce phase II and phase III human trials of COVID-19 vaccine - Republic World

Bloomberg - Are you a robot?

The speed in developing vaccines for widespread testing this summer is impressive, but running trials involving tens of thousands of people will be an immense undertaking.The speed in developing vaccines so far is impressive, but running trials this summer involving tens of thousands of people will be a tough challenge.

Op-Ed: Fast coronavirus vaccine could bring problems - Los Angeles Times

“This is what our government is paying to develop a COVID19 vaccine: - $1.2 billion to AstraZeneca - $483 million to Moderna - $500 million to Johnson & Johnson - $30 million to Sanofi Once a vaccine is approved by the FDA, it must be available to all for free. No profiteering.”

Bernie Sanders on Twitter: "This is what our government is paying to develop a COVID19 vaccine: - $1.2 billion to AstraZeneca - $483 million to Moderna - $500 million to Johnson & Johnson - $30 million to Sanofi Once a vaccine is approved by the FDA, it must be available to all for free. No profiteering."

“Oxford, AstraZeneca begin advanced trials of Covid vaccine @LauermanJohn reports https://t.co/baA6VZECin”

Shekhar Gupta on Twitter: "Oxford, AstraZeneca begin advanced trials of Covid vaccine @LauermanJohn reports https://t.co/baA6VZECin"

“$JNJ Chinese Covid-19 Vaccine Trial Results Are a Good Sign for J&J and AstraZeneca’s Efforts https://t.co/u2qIOVySFY”

Ophir Gottlieb on Twitter: "$JNJ Chinese Covid-19 Vaccine Trial Results Are a Good Sign for J&J and AstraZeneca’s Efforts https://t.co/u2qIOVySFY"

“US provides AstraZeneca with $1 billion for COVID-19 vaccine #GeoNews”

Geo English on Twitter: "US provides AstraZeneca with $1 billion for COVID-19 vaccine #GeoNews"

THE US has purchased around 300 million COVID-19 vaccines from AsteaZeneca.THE US has purchased around 300 million COVID-19 vaccines from AsteaZeneca.

Coronavirus US: 300 million AstraZeneca vaccines bought | World | News | Express.co.uk

THOUSANDS more volunteers are needed for the latest rounds of clinical trials for a promising coronavirus vaccine. Researchers say their world- ­leading jab is “progressing very well” and it is rea…

Thousands of volunteers needed for latest clinical trials of ‘promising’ coronavirus vaccine – The Sun

The US government will make as much as $1.2 billion available to accelerate testing and production of a potential Covid-19 vaccine developed by the University of Oxford.Astrazeneca, the drugmakerThe US government will make as much as $1.2 billion available to accelerate testing and production of a potential Covid-19 vaccine developed by the University of Oxford.Astrazeneca, the drugmaker

The London Economic |"That is going to mean a lot of elderly are going to die and those with heart conditions and diabetes and other risk factors.' | NewsThe London Economic |"That is going to mean a lot of elderly are going to die and those with heart conditions and diabetes and other risk factors.' | News

Herd immunity without vaccine or treatment is a 'Darwinian policy'

The University of Oxford said on Friday that its researchers have begun recruiting adults and children for advanced human trials of a COVID-19 vaccine that will involve up to 10,260 volunteers across the UKThe University of Oxford said on Friday that its researchers have begun recruiting adults and children for advanced human trials of a COVID-19 vaccine that will involve up to 10,260 volunteers across the UK

Oxford COVID-19 vaccine enters advanced human trials

The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.

Coronavirus vaccine safe in early trial, hydroxychloroquine may increase death risk - Reuters

LONDON: British researchers testing an experimental vaccine against the new coronavirus are moving into advanced studies and aim to immunize more than 10,000 people to determine if the shot works. Last month, scientists at Oxford University began immunizing more than 1,000 volunteers with their vaccine candidate in a preliminary trial designed to test the shot’s safety. OnLONDON: British researchers testing an experimental vaccine against the new coronavirus are moving into advanced studies and aim to immunize more than 10,000 people to determine if the shot works.

UK’s COVID-19 study aims to vaccinate more than 10,000 | Arab News

Early progress has been reported on several vaccine efforts, as scientists around the world scramble to test ways to protect people from the coronavirus.Early progress has been reported on several vaccine efforts, as scientists around the world scramble to test ways to protect people from the coronavirus.

UK News: LONDON: Clinical trials to test Oxford University’s new vaccine for Covid-19 are “progressing very well”, the head of the Oxford Vaccine Group (OVG) s.UK News: LONDON: Clinical trials to test Oxford University’s new vaccine for Covid-19 are “progressing very well”, the head of the Oxford Vaccine Group (OVG) s.

Oxford vaccine clinical trials are 'going well' - Times of India

British researchers testing an experimental vaccine against the new coronavirus are moving into advanced studies and aim to immunize more than 10,000 people to determine if the shot works.

UK to start huge vaccine test; China reports promising hints (Update)

Pending the results of a Phase III efficacy trial this summer, a vaccine produced by the biotech company Moderna could be ready for approval as soon as the fall.Pending the results of a Phase III efficacy trial this summer, a vaccine produced by the biotech company Moderna could be ready for approval as soon as the fall.

The Coronavirus Vaccine Is on Track to Be the Fastest Ever Developed | The New Yorker

The United States has secured almost a third of the first one billion doses planned for AstraZeneca's experimental COVID-19 vaccine by pledging up to $1.2 billion, as world powers scramble for medicines to get their economies back to work.The United States has secured almost a third of the first one billion doses planned for AstraZeneca's experimental COVID-19 vaccine by pledging up to $1.2 billion, as world powers scramble for medicines to get their economies back to work.

‘America first’: US secures 300 million doses of potential UK COVID-19 vaccine – EURACTIV.com

Reuters report on the vaccine trial The US plans a massive round of phase 2 vaccine trials in an effort to speed up the timeline for vaccine development to have a mass candidate ready by year-end. By Adam ButtonReuters report on the vaccine trial The US plans a massive round of phase 2 vaccine trials in an effort to speed up the timeline for vaccine development to have a mass candidate ready by year-end.

US will test vaccines on more than 100,000 people starting in July - report

Four of the biotech's top executives netted a total of $30 million since positive results for a coronavirus vaccine were touted.Four of the biotech's top executives netted a total of $30 million since positive results for a coronavirus vaccine were touted.

Moderna CEO and other execs made millions on vaccine announcement - CBS News

US secures 300 million. Read more at straitstimes.com.World News -US secures 300 million. Read more at straitstimes.com.

In Brief: US secures 300 million possible vaccine doses, World News & Top Stories - The Straits Times

Biotech companies and drugmakers are speeding up development of a vaccine for COVID-19. This has seen many big players joining forces to come up with a treatment.Biotech companies and drugmakers are speeding up development of a vaccine for COVID-19. This has seen many big players joining forces to come up with a treatment.

Coronavirus Vaccine Race Pushes Up Pharma Giants' Production

British pharmaceutical company AstraZeneca says it is ready to provide a potential vaccine against the new coronavirus from September.British pharmaceutical company AstraZeneca says it is ready to provide a potential vaccine against the new coronavirus from September.

British firm ready to supply vaccine in September | NHK WORLD-JAPAN News

RTL Today - Second-highest death toll: Virus-stung UK banks on vaccine drive

Researchers at Oxford University said on Friday that they would move to the next phase of testing, expanding from 1,000 people to some 10,000 more.Researchers at Oxford University said on Friday that they would move to the next phase of testing, expanding from 1,000 people to some 10,000 more.

Oxford vaccine 'progressing very well,' 10,000 more to be inoculated - Business Insider

LONDON, May 22 — The United States has secured almost a third of the first 1 billion doses planned for AstraZeneca's experimental Covid-19 vaccine by pledging up to US$1.2 billion (RM5.22 billion), as world powers scramble for medicines to get their economies back to work. While not yet proven to...LONDON, May 22 — The United States has secured almost a third of the first 1 billion doses planned for AstraZeneca's experimental Covid-19 vaccine by pledging up to US$1.2 billion (RM5.22 billion), as world powers scramble for medicines to get their economies back to work. While not yet proven to...

US secures 300 million doses of potential AstraZeneca Covid-19 vaccine | World | Malay Mail

Here is a preview of the top Covid-19 news today from India and the world.Here is a preview of the top Covid-19 news today from India and the world.

RBI cuts key rate, Oxford vaccine trials in next phase: Covid-19 news today - india news - Hindustan Times

Follow along with this live blog for all the latest coronavirus updates and developments from across Scotland.Follow along with this live blog for all the latest coronavirus updates and developments from across Scotland.

Coronavirus in Scotland RECAP: Police vow fines 'last resort' as lockdown continues | Greenock Telegraph

The firm AstraZeneca has concluded deals for 400 million doses of the vaccine currently being developed within Oxford University. The company said that it is capable of producing over one billion doses of the AZD1222 vaccine for this year and the next.The firm AstraZeneca has concluded deals for 400 million doses of the vaccine currently being developed within Oxford University. The company said that it is capable of producing over one billion doses of the AZD1222 vaccine for this year and the next.

COVID-19 Vaccine: AstraZeneca to Supply 400 Million Potential Vaccines by September After Partnering with Oxford University | Tech Times

AstraZeneca has announced a deal to distribute 400 million doses of Oxford Uni's coronavirus vaccine, but the vaccine may not work.AstraZeneca has announced a deal to distribute 400 million doses of Oxford Uni's coronavirus vaccine, but the vaccine may not work.

3 Reasons Why Oxford’s Record-Breaking COVID-19 Vaccine is a Risky Bet

Countries across the world are pinning their hopes on the Oxford University's vaccine with pharma behemoths like AstraZeneca already aboard for the expeditious production of the vaccine.Countries across the world are pinning their hopes on the Oxford University's vaccine with pharma behemoths like AstraZeneca already aboard for the expeditious production of the vaccine.

Coronavirus vaccine: Oxford University, AstraZeneca start advanced trials of COVID-19 drugs

A VACCINE may not be possible for the coronavirus, according to Scotland’s national clinical director.A VACCINE may not be possible for the coronavirus, according to Scotland’s national clinical director.

Jason Leitch warns vaccine may never be found for coronavirus | The National

Oxford University and AstraZeneca are recruiting around 10,000 adults and children in Britain for trials of an experimental coronavirus vaccine, ...Oxford University and AstraZeneca are recruiting around 10,000 adults and children in Britain for trials of an experimental coronavirus vaccine, ...

Human trials of British coronavirus vaccine to reach 10,000 - CNA

AstraZeneca is partnering with University of Oxford to develop and distribute a vaccine being trialled in the UKAstraZeneca is partnering with University of Oxford to develop and distribute a vaccine being trialled in the UK

US provides AstraZeneca with $1 billion for COVID-19 vaccine

NoCookies | The Australian

A team from Oxford University told NBC News that the expanded trial will allow doctors to determine how effective the shot is at preventing COVID-19.A promising experimental vaccine for the coronavirus hit a milestone Friday, with British researchers announcing they will be progressing to advanced stages of human trials. The team from

Coronavirus vaccine shows promise, progresses to advanced trial

AstraZeneca, a drugmaker to produced Oxford University's potential COVID-19 vaccine, says it looks to begin supply in September if clinical trials succeed.AstraZeneca, a drugmaker to produced Oxford University's potential COVID-19 vaccine, says it looks to begin supply in September if clinical trials succeed.

Potential COVID-19 vaccine could be ready in September, says AstraZeneca - TheCable Lifestyle

Human trials continue as country's death toll climbs to 36,393 - Anadolu AgencyHuman trials continue as country's death toll climbs to 36,393 - Anadolu Agency

UK: Oxford vaccine goes to human trials' next phase

The Oxford trial will monitor the effects on thousands of people's immune systems.The Oxford trial will monitor the effects on thousands of people's immune systems.

Coronavirus: Children and older adults to take part in vaccine trial - BBC News

AstraZeneca is also in discussions with the Serum Institute of India and other potential partners to increase production and distribution.AstraZeneca is also in discussions with the Serum Institute of India and other potential partners to increase production and distribution.

AstraZeneca receives $1bn US investment for Oxford vaccine, Health News, ET HealthWorld

On Friday, the University of Oxford said that the researchers have begun recruiting adults and children for advanced human trials of the vaccine.On Friday, the University of Oxford said that the researchers have begun recruiting adults and children for advanced human trials of the vaccine.

MOSCOW: Preclinical testing of a vaccine against the coronavirus conducted by the Gamaleya Scientific Research Institute of Epidemiology and Microbiol...MOSCOW: Preclinical testing of a vaccine against the coronavirus conducted by the Gamaleya Scientific Research Institute of Epidemiology and Microbiol...

Human trials of Covid-19 vaccine by Russian Gamaleya Institute expected by June 15

The coronavirus vaccine race delivers more promising news, as the US invested $1.2 billion to speed up development and secure 300 million doses for the breakthrough Oxford candidate.The coronavirus vaccine race delivers more promising news, as the US invested $1.2 billion to speed up development and secure 300 million doses for the breakthrough Oxford candidate. The novel coro…

US secures 300M doses of coronavirus vaccine candidate from Oxford – BGR

Just a moment...

British researchers testing an experimental vaccine against the new coronavirus aim to immunize more than 10,000 people to find out if it works.British researchers testing an experimental vaccine against the new coronavirus aim to immunize more than 10,000 people to find out if it works.

Over 10,000 to receive potential COVID-19 vaccine in U.K. as tests expand - National | Globalnews.ca

By pledging up to $1.2 billion in assistance, the Department of Health and Human Services has ensured its access to a large supply of the ChAdOx1 nCoV-19 vaccine -- assuming it works.By pledging up to $1.2 billion in assistance, the Department of Health and Human Services has ensured its access to a large supply of the ChAdOx1 nCoV-19 vaccine -- assuming it works.

U.S. Seals Deal with AstraZeneca for 300 Million Doses of Potential Coronavirus Vaccine | The Motley Fool

THE United States has secured almost a third of AstraZeneca's one billion possible Covid-19 vaccine doses by pledging up to US$1.2 billion, as the world's biggest powers scramble for medicinal supplies to get their economies back to work. Read more at The Business Times.THE United States has secured almost a third of AstraZeneca's one billion possible Covid-19 vaccine doses by pledging up to US$1.2 billion, as the world's biggest powers scramble for medicinal

US secures 300 million doses of potential Covid-19 vaccine, Government & Economy - THE BUSINESS TIMES

News, analysis and comment from the Financial Times, the worldʼs leading global business publication

Subscribe to read | Financial Times